Profile data is unavailable for this security.
About the company
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
- Revenue in USD (TTM)65.56m
- Net income in USD17.19m
- Incorporated2014
- Employees148.00
- LocationIRadimed Corp1025 Willa Springs Dr.WINTER SPRINGS 32708United StatesUSA
- Phone+1 (407) 677-8022
- Fax+1 (302) 636-5454
- Websitehttp://www.iradimed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | 0.00 | -42.21m | 369.46m | 56.00 | -- | 8.32 | -- | -- | -0.8936 | -0.8936 | 0.00 | 0.8044 | 0.00 | -- | -- | 0.00 | -61.61 | -93.21 | -67.89 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| Pacific Biosciences of California Inc | 200.52m | -306.74m | 369.77m | 796.00 | -- | 0.5269 | -- | 1.84 | -1.21 | -1.21 | 0.7907 | 2.62 | 0.1142 | 2.70 | 7.24 | 251,910.80 | -17.46 | -16.19 | -19.45 | -17.81 | 28.03 | 37.35 | -152.97 | -136.21 | 7.21 | -22.45 | 0.5601 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Surmodics Inc | 138.20m | 5.52m | 372.56m | 376.00 | 66.92 | 3.05 | 26.14 | 2.70 | 0.3911 | 0.3911 | 9.82 | 8.58 | 0.7897 | 2.10 | 7.05 | 367,561.20 | 3.15 | -1.85 | 3.49 | -2.18 | 79.38 | 82.93 | 3.99 | -2.98 | 3.97 | 5.84 | 0.1942 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
| Neuropace Inc | 65.42m | -32.96m | 373.07m | 171.00 | -- | 17.50 | -- | 5.70 | -1.28 | -1.28 | 2.53 | 0.7423 | 0.590 | 1.65 | 6.61 | 382,578.90 | -29.72 | -- | -33.88 | -- | 73.56 | -- | -50.38 | -- | 5.02 | -4.97 | 0.7339 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| MaxCyte Inc | 41.29m | -37.92m | 385.22m | 143.00 | -- | 1.65 | -- | 9.33 | -0.3675 | -0.3675 | 0.3998 | 2.23 | 0.1488 | 0.4558 | 4.27 | 288,727.30 | -13.67 | -13.18 | -14.54 | -14.33 | 88.51 | 88.79 | -91.85 | -62.96 | 9.97 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| ZimVie Inc | 457.43m | -56.05m | 421.38m | 2.60k | -- | 1.02 | -- | 0.9212 | -2.12 | -14.87 | 17.33 | 15.12 | 0.3213 | 1.07 | 3.91 | 175,935.80 | -3.94 | -- | -4.56 | -- | 63.48 | 65.51 | -12.25 | -8.73 | 2.32 | -0.5562 | 0.5541 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Nevro Corp | 425.17m | -92.21m | 426.24m | 1.22k | -- | 1.44 | -- | 1.00 | -2.57 | -2.57 | 11.82 | 8.06 | 0.6868 | 1.24 | 5.37 | 349,937.40 | -14.90 | -13.64 | -17.15 | -16.68 | 68.22 | 68.54 | -21.69 | -20.67 | 4.94 | -- | 0.4191 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| Orthofix Medical Inc | 746.64m | -151.40m | 490.03m | 1.63k | -- | 0.8132 | -- | 0.6563 | -4.15 | -4.15 | 20.33 | 16.11 | 1.08 | 1.62 | 7.08 | 456,940.60 | -21.88 | -8.88 | -26.68 | -10.96 | 65.13 | 72.37 | -20.28 | -9.28 | 1.20 | -16.11 | 0.1595 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Nano-X Imaging Ltd | 9.91m | -60.78m | 515.39m | 180.00 | -- | 2.64 | -- | 52.03 | -1.08 | -1.08 | 0.1758 | 3.38 | 0.0419 | -- | 8.05 | -- | -25.72 | -30.98 | -28.14 | -35.10 | -66.55 | -- | -613.59 | -1,527.24 | 5.56 | -- | 0.0175 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Iradimed Corp | 65.56m | 17.19m | 525.13m | 148.00 | 30.70 | 7.35 | 29.24 | 8.01 | 1.35 | 1.35 | 5.15 | 5.64 | 0.738 | 1.69 | 5.14 | 442,988.50 | 19.35 | 13.16 | 22.51 | 14.58 | 76.50 | 76.55 | 26.22 | 21.46 | 3.87 | -- | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| SI-Bone Inc | 138.89m | -43.34m | 585.99m | 344.00 | -- | 3.43 | -- | 4.22 | -1.13 | -1.13 | 3.62 | 4.16 | 0.716 | 1.57 | 6.52 | 403,738.40 | -22.34 | -27.88 | -25.24 | -30.94 | 78.78 | 85.03 | -31.20 | -51.09 | 8.15 | -- | 0.1756 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Embecta Corp | 1.12bn | 55.30m | 598.82m | 2.20k | 10.84 | -- | 6.66 | 0.5335 | 0.9598 | 0.9598 | 19.47 | -13.78 | 0.9296 | 2.57 | 19.35 | 510,181.80 | 4.58 | -- | 6.44 | -- | 66.55 | -- | 4.93 | -- | 1.75 | 1.67 | 1.94 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Fulgent Genetics Inc | 289.21m | -167.83m | 598.91m | 1.18k | -- | 0.5228 | -- | 2.07 | -5.64 | -5.64 | 9.71 | 38.31 | 0.2207 | -- | 5.57 | 244,267.70 | -13.37 | 16.70 | -14.25 | 18.37 | 36.12 | 67.89 | -60.59 | 29.06 | -- | -- | 0.0048 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Jin Medical International Ltd | 19.98m | 3.25m | 613.66m | 269.00 | 175.63 | 25.80 | 171.49 | 30.72 | 0.0223 | 0.0223 | 0.1353 | 0.1519 | 0.7557 | 1.85 | 5.00 | 74,260.52 | 12.28 | -- | 16.62 | -- | 33.02 | -- | 16.25 | -- | 3.02 | -- | 0.0582 | -- | -7.58 | -- | 2.84 | -- | -- | -- |
| Treace Medical Concepts Inc | 187.12m | -49.53m | 637.94m | 516.00 | -- | 4.61 | -- | 3.41 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Varex Imaging Corp | 877.80m | 44.60m | 686.14m | 2.30k | 25.18 | 1.21 | 8.69 | 0.7817 | 0.6712 | 0.6712 | 16.65 | 14.01 | 0.7245 | 1.95 | 5.90 | 365,750.00 | 3.72 | 0.9913 | 4.32 | 1.18 | 32.37 | 31.70 | 5.14 | 1.36 | 2.37 | 2.85 | 0.4322 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
Data as of Apr 26 2024. Currency figures normalised to IRadimed Corp's reporting currency: US Dollar USD
34.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nine Ten Capital Management LLCas of 31 Dec 2023 | 799.37k | 6.31% |
| Soleus Capital Management LP (Investment Management)as of 31 Dec 2023 | 643.21k | 5.08% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 580.21k | 4.58% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 498.28k | 3.94% |
| Copeland Capital Management LLCas of 31 Mar 2024 | 418.15k | 3.30% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 406.66k | 3.21% |
| RK Capital Management LLCas of 31 Dec 2023 | 340.40k | 2.69% |
| Bares Capital Management, Inc.as of 31 Dec 2023 | 277.00k | 2.19% |
| Ranger Investment Management LPas of 31 Dec 2023 | 223.61k | 1.77% |
| Russell Investment Management LLCas of 31 Dec 2023 | 211.29k | 1.67% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
